| | Symbol | Genename | TEL-AML1 score | other score |
|---|
| 36239_at | POU2AF1 | POU domain, class 2, associating factor 1 | 0.9726 | -0.3065 |
|---|
| 33162_at | INSR | insulin receptor | 0.7571 | -0.2386 |
|---|
| 40570_at | FOXO1A | forkhead box O1A (rhabdomyosarcoma) | 0.6649 | -0.2095 |
|---|
| 36638_at | CTGF | connective tissue growth factor | 0.6374 | -0.2009 |
|---|
| 34481_at | VAV1 | vav 1 oncogene | 0.6293 | -0.1983 |
|---|
| 40367_at | BMP2 | bone morphogenetic protein 2 | 0.6146 | -0.1937 |
|---|
| 1113_at | BMP2 | bone morphogenetic protein 2 | 0.5701 | -0.1797 |
|---|
| 1779_s_at | PIM1 | pim-1 oncogene | 0.5546 | -0.1748 |
|---|
| 34525_at | TCL1B | T-cell leukemia/lymphoma 1B | 0.5496 | -0.1732 |
|---|
| 883_s_at | PIM1 | pim-1 oncogene | 0.5009 | -0.1579 |
|---|
| 1919_at | VAV1 | vav 1 oncogene | 0.4692 | -0.1479 |
|---|
| 1572_s_at | INSR | insulin receptor | 0.452 | -0.1424 |
|---|
| 40019_at | EVI2B | ecotropic viral integration site 2B | -0.4482 | 0.1412 |
|---|
| 33387_at | GAS7 | growth arrest-specific 7 | -0.3716 | 0.1171 |
|---|
| 40480_s_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.3559 | 0.1122 |
|---|
| 41175_at | CBFB | core-binding factor, beta subunit | -0.3529 | 0.1112 |
|---|
| 39712_at | S100A13 | S100 calcium binding protein A13 | -0.34 | 0.1072 |
|---|
| 34299_at | ZNF278 | zinc finger protein 278 | 0.3397 | -0.107 |
|---|
| 1915_s_at | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | -0.3298 | 0.1039 |
|---|
| 36805_s_at | NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.3285 | -0.1035 |
|---|
| 2039_s_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.3279 | 0.1033 |
|---|
| 1892_s_at | TPM3 | tropomyosin 3 | 0.3265 | -0.1029 |
|---|
| 32874_at | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.3164 | -0.0997 |
|---|
| 37194_at | GATA2 | GATA binding protein 2 | 0.2937 | -0.0925 |
|---|
| 40091_at | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | -0.2924 | 0.0921 |
|---|
| 1916_s_at | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | -0.2887 | 0.091 |
|---|
| 840_at | MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.2822 | -0.0889 |
|---|
| 2094_s_at | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | -0.2802 | 0.0883 |
|---|
| 34316_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.2748 | 0.0866 |
|---|
| 1782_s_at | STMN1 | stathmin 1/oncoprotein 18 | 0.2694 | -0.0849 |
|---|
| 1826_at | ARHB | ras homolog gene family, member B | -0.2615 | 0.0824 |
|---|
| 1856_at | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.2574 | -0.0811 |
|---|
| 1373_at | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.2571 | -0.081 |
|---|
| 40412_at | PTTG1 | pituitary tumor-transforming 1 | -0.2544 | 0.0802 |
|---|
| 34300_at | ZNF278 | zinc finger protein 278 | 0.2394 | -0.0754 |
|---|
| 32184_at | LMO2 | LIM domain only 2 (rhombotin-like 1) | -0.235 | 0.0741 |
|---|
| 39318_at | TCL1A | T-cell leukemia/lymphoma 1A | 0.2305 | -0.0727 |
|---|
| 36951_at | MRPL49 | mitochondrial ribosomal protein L49 | 0.2294 | -0.0723 |
|---|
| 1374_g_at | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.2242 | -0.0707 |
|---|
| 39159_at | SH3GL1 | SH3-domain GRB2-like 1 | 0.2239 | -0.0705 |
|---|
| 41504_s_at | MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | -0.2233 | 0.0704 |
|---|
| 33253_at | TRIM14 | tripartite motif-containing 14 | -0.2231 | 0.0703 |
|---|
| 40189_at | SET | SET translocation (myeloid leukemia-associated) | -0.2202 | 0.0694 |
|---|
| 203_at | GATA2 | GATA binding protein 2 | 0.2194 | -0.0691 |
|---|
| 38992_at | DEK | DEK oncogene (DNA binding) | -0.2121 | 0.0668 |
|---|
| 31526_f_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | 0.2032 | -0.064 |
|---|
| 2059_s_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.2028 | 0.0639 |
|---|
| 361_at | BCL9 | B-cell CLL/lymphoma 9 | 0.2009 | -0.0633 |
|---|
| 1394_at | ARHA | ras homolog gene family, member A | -0.2005 | 0.0632 |
|---|
| 37663_at | DDX1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 | -0.1986 | 0.0626 |
|---|
| 1796_s_at | BCL3 | B-cell CLL/lymphoma 3 | 0.1977 | -0.0623 |
|---|
| 1518_at | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.1976 | -0.0623 |
|---|
| 36120_at | FVT1 | follicular lymphoma variant translocation 1 | -0.1951 | 0.0615 |
|---|
| 35340_at | RAB8A | RAB8A, member RAS oncogene family | -0.1931 | 0.0609 |
|---|
| 34317_g_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.1913 | 0.0603 |
|---|
| 40203_at | SUI1 | putative translation initiation factor | -0.1867 | 0.0588 |
|---|
| 33238_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.1867 | 0.0588 |
|---|
| 1071_at | GATA2 | GATA binding protein 2 | 0.1858 | -0.0586 |
|---|
| 39511_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.184 | -0.058 |
|---|
| 40661_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.1798 | -0.0567 |
|---|
| 40479_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.1796 | 0.0566 |
|---|
| 943_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.1769 | -0.0557 |
|---|
| 39421_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.1735 | -0.0547 |
|---|
| 33355_at | PBX1 | pre-B-cell leukemia transcription factor 1 | -0.1734 | 0.0547 |
|---|
| 1706_at | ARAF1 | v-raf murine sarcoma 3611 viral oncogene homolog 1 | -0.169 | 0.0533 |
|---|
| 38118_at | SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | -0.1688 | 0.0532 |
|---|
| 393_s_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.1643 | -0.0518 |
|---|
| 34669_at | TFE3 | transcription factor binding to IGHM enhancer 3 | -0.1641 | 0.0517 |
|---|
| 772_at | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.1595 | -0.0503 |
|---|
| 40648_at | MERTK | c-mer proto-oncogene tyrosine kinase | -0.1584 | 0.0499 |
|---|
| 36592_at | PHB | prohibitin | -0.1565 | 0.0493 |
|---|
| 37309_at | ARHA | ras homolog gene family, member A | -0.1562 | 0.0492 |
|---|
| 567_s_at | PML | promyelocytic leukemia | 0.1472 | -0.0464 |
|---|
| 32827_at | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.1443 | -0.0455 |
|---|
| 1786_at | MERTK | c-mer proto-oncogene tyrosine kinase | -0.1441 | 0.0454 |
|---|
| 38788_at | PML | promyelocytic leukemia | 0.1394 | -0.0439 |
|---|
| 34665_g_at | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | -0.1392 | 0.0439 |
|---|
| 477_at | IRF5 | interferon regulatory factor 5 | 0.1386 | -0.0437 |
|---|
| 36437_s_at | RANBP9 | RAN binding protein 9 | -0.1367 | 0.0431 |
|---|
| 41505_r_at | MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | -0.1355 | 0.0427 |
|---|
| 37448_s_at | GNAS | GNAS complex locus | 0.1354 | -0.0427 |
|---|
| 1547_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 0.1352 | -0.0426 |
|---|
| 32583_at | JUN | v-jun sarcoma virus 17 oncogene homolog (avian) | -0.1344 | 0.0424 |
|---|
| 40659_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.1343 | -0.0423 |
|---|
| 719_g_at | PRSS11 | protease, serine, 11 (IGF binding) | 0.1326 | -0.0418 |
|---|
| 1341_at | SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | -0.1323 | 0.0417 |
|---|
| 40481_r_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.1321 | 0.0416 |
|---|
| 718_at | PRSS11 | protease, serine, 11 (IGF binding) | 0.131 | -0.0413 |
|---|
| 36935_at | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | -0.1304 | 0.0411 |
|---|
| 40362_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.1278 | -0.0403 |
|---|
| 40957_at | JJAZ1 | joined to JAZF1 | -0.127 | 0.04 |
|---|
| 34663_at | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | -0.1269 | 0.04 |
|---|
| 1859_s_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.1263 | -0.0398 |
|---|
| 1072_g_at | GATA2 | GATA binding protein 2 | 0.1263 | -0.0398 |
|---|
| 39149_at | PRCC | papillary renal cell carcinoma (translocation-associated) | -0.1263 | 0.0398 |
|---|
| 35629_at | MKL1 | megakaryoblastic leukemia (translocation) 1 | -0.125 | 0.0394 |
|---|
| 31631_f_at | PTTG2 | pituitary tumor-transforming 2 | -0.1242 | 0.0391 |
|---|
| 37450_r_at | GNAS | GNAS complex locus | 0.1226 | -0.0386 |
|---|
| 37449_i_at | GNAS | GNAS complex locus | 0.1226 | -0.0386 |
|---|
| 39989_at | RRAGB | Ras-related GTP binding B | -0.1223 | 0.0385 |
|---|
| 36593_at | EXT2 | exostoses (multiple) 2 | -0.1223 | 0.0385 |
|---|
| 1232_s_at | IGFBP1 | insulin-like growth factor binding protein 1 | 0.1216 | -0.0383 |
|---|
| 1674_at | YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.1216 | -0.0383 |
|---|
| 37809_at | HOXA9 | homeo box A9 | -0.1214 | 0.0382 |
|---|
| 38219_at | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.1207 | -0.038 |
|---|
| 35772_at | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.1199 | -0.0378 |
|---|
| 32694_at | RARB | retinoic acid receptor, beta | 0.1198 | -0.0378 |
|---|
| 1909_at | BCL2 | B-cell CLL/lymphoma 2 | 0.1175 | -0.037 |
|---|
| 32063_at | PBX1 | pre-B-cell leukemia transcription factor 1 | -0.1172 | 0.037 |
|---|
| 780_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.117 | -0.0369 |
|---|
| 1940_at | KRAS2 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | -0.1154 | 0.0364 |
|---|
| 37846_at | GRAF | GTPase regulator associated with focal adhesion kinase pp125(FAK) | 0.1149 | -0.0362 |
|---|
| 36594_s_at | EXT2 | exostoses (multiple) 2 | -0.1149 | 0.0362 |
|---|
| 1474_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1143 | 0.036 |
|---|
| 36941_at | AF1Q | ALL1-fused gene from chromosome 1q | 0.1112 | -0.035 |
|---|
| 38813_at | TSC2 | tuberous sclerosis 2 | 0.111 | -0.035 |
|---|
| 37339_at | USP4 | ubiquitin specific protease 4 (proto-oncogene) | -0.1107 | 0.0349 |
|---|
| 888_s_at | GDF1 | growth differentiation factor 1 | 0.1103 | -0.0348 |
|---|
| 40422_at | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | -0.11 | 0.0347 |
|---|
| 35915_at | INHBC | inhibin, beta C | 0.1088 | -0.0343 |
|---|
| 1675_at | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | -0.1086 | 0.0342 |
|---|
| 31609_s_at | PCOLCE | procollagen C-endopeptidase enhancer | 0.1081 | -0.0341 |
|---|
| 1476_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.108 | 0.0341 |
|---|
| 35339_at | RAB8A | RAB8A, member RAS oncogene family | -0.1075 | 0.0339 |
|---|
| 32582_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | -0.1063 | 0.0335 |
|---|
| 40332_at | OGFR | opioid growth factor receptor | 0.1054 | -0.0332 |
|---|
| 33850_at | SUI1 | putative translation initiation factor | -0.1053 | 0.0332 |
|---|
| 37279_at | GEM | GTP binding protein overexpressed in skeletal muscle | 0.1046 | -0.033 |
|---|
| 1638_at | ETV6 | ets variant gene 6 (TEL oncogene) | -0.1039 | 0.0327 |
|---|
| 31663_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.1035 | -0.0326 |
|---|
| 702_f_at | HSHPX5 | HPX-5 | 0.1031 | -0.0325 |
|---|
| 39681_at | ZNF145 | zinc finger protein 145 (Kruppel-like, expressed in promyelocytic leukemia) | 0.103 | -0.0325 |
|---|
| 35641_g_at | CBFA2T1 | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | 0.1027 | -0.0324 |
|---|
| 39350_at | GPC3 | glypican 3 | 0.1027 | -0.0324 |
|---|
| 1736_at | IGFBP6 | insulin-like growth factor binding protein 6 | -0.1024 | 0.0323 |
|---|
| 2042_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1016 | 0.032 |
|---|
| 38650_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0985 | 0.0311 |
|---|
| 41500_at | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.096 | -0.0302 |
|---|
| 35608_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.0955 | -0.0301 |
|---|
| 41339_at | UBE4B | ubiquitination factor E4B (UFD2 homolog, yeast) | -0.0936 | 0.0295 |
|---|
| 33474_at | GLI | glioma-associated oncogene homolog (zinc finger protein) | -0.0924 | 0.0291 |
|---|
| 767_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.0919 | -0.029 |
|---|
| 35328_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0911 | -0.0287 |
|---|
| 37407_s_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.0902 | -0.0284 |
|---|
| 1741_s_at | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | -0.089 | 0.028 |
|---|
| 32018_at | BCAS4 | breast carcinoma amplified sequence 4 | -0.0886 | 0.0279 |
|---|
| 33884_s_at | UBE4B | ubiquitination factor E4B (UFD2 homolog, yeast) | -0.0881 | 0.0278 |
|---|
| 871_s_at | HLF | hepatic leukemia factor | 0.0881 | -0.0278 |
|---|
| 35200_at | HMGA2 | high mobility group AT-hook 2 | 0.0874 | -0.0275 |
|---|
| 40357_at | INHBA | inhibin, beta A (activin A, activin AB alpha polypeptide) | -0.087 | 0.0274 |
|---|
| 1707_g_at | ARAF1 | v-raf murine sarcoma 3611 viral oncogene homolog 1 | -0.0858 | 0.027 |
|---|
| 1473_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.0858 | 0.027 |
|---|
| 1613_s_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | -0.0853 | 0.0269 |
|---|
| 544_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.0852 | -0.0269 |
|---|
| 37461_at | ANGPT2 | angiopoietin 2 | -0.085 | 0.0268 |
|---|
| 1677_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0847 | 0.0267 |
|---|
| 38787_at | PML | promyelocytic leukemia | 0.0843 | -0.0266 |
|---|
| 2006_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 0.0831 | -0.0262 |
|---|
| 2017_s_at | CCND1 | cyclin D1 (PRAD1 | 0.0829 | -0.0261 |
|---|
| 1519_at | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.082 | -0.0258 |
|---|
| 1174_at | MOS | v-mos Moloney murine sarcoma viral oncogene homolog | -0.0819 | 0.0258 |
|---|
| 1847_s_at | BCL2 | B-cell CLL/lymphoma 2 | 0.0819 | -0.0258 |
|---|
| 1472_g_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.0813 | 0.0256 |
|---|
| 41420_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0809 | 0.0255 |
|---|
| 1475_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.0806 | 0.0254 |
|---|
| 1895_at | JUN | v-jun sarcoma virus 17 oncogene homolog (avian) | -0.0806 | 0.0254 |
|---|
| 1337_s_at | RARA | retinoic acid receptor, alpha | -0.08 | 0.0252 |
|---|
| 39174_at | NCOA4 | nuclear receptor coactivator 4 | -0.0791 | 0.0249 |
|---|
| 38140_at | EXTL1 | exostoses (multiple)-like 1 | 0.0787 | -0.0248 |
|---|
| 40978_s_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.0784 | 0.0247 |
|---|
| 126_s_at | SSX2 | synovial sarcoma, X breakpoint 2 | 0.0781 | -0.0246 |
|---|
| 38639_at | MXD4 | MAX dimerization protein 4 | -0.0772 | 0.0243 |
|---|
| 255_s_at | INHA | inhibin, alpha | -0.0761 | 0.024 |
|---|
| 1538_s_at | IL2 | interleukin 2 | 0.076 | -0.024 |
|---|
| 41620_at | DOCK4 | dedicator of cytokinesis 4 | 0.0754 | -0.0238 |
|---|
| 31798_at | TFF1 | trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) | 0.0724 | -0.0228 |
|---|
| 2043_s_at | BCR | breakpoint cluster region | -0.072 | 0.0227 |
|---|
| 36238_at | MLLT7 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7 | 0.0718 | -0.0226 |
|---|
| 423_at | EWSR1 | Ewing sarcoma breakpoint region 1 | -0.0713 | 0.0225 |
|---|
| 40312_at | DACH | dachshund homolog (Drosophila) | -0.0706 | 0.0223 |
|---|
| 1838_g_at | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.0703 | -0.0221 |
|---|
| 774_g_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.0701 | -0.0221 |
|---|
| 41571_at | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.0696 | -0.0219 |
|---|
| 401_s_at | HLF | hepatic leukemia factor | 0.0689 | -0.0217 |
|---|
| 38544_at | INHA | inhibin, alpha | 0.0668 | -0.0211 |
|---|
| 2038_g_at | BCL2 | B-cell CLL/lymphoma 2 | -0.0666 | 0.021 |
|---|
| 40575_at | DLG5 | discs, large homolog 5 (Drosophila) | -0.0641 | 0.0202 |
|---|
| 34021_at | IL2 | interleukin 2 | -0.0638 | 0.0201 |
|---|
| 38739_at | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.0634 | -0.02 |
|---|
| 35638_at | CBFA2T1 | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | 0.0634 | -0.02 |
|---|
| 33862_at | PPAP2B | phosphatidic acid phosphatase type 2B | 0.0633 | -0.0199 |
|---|
| 41572_r_at | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.0623 | -0.0196 |
|---|
| 33900_at | FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.062 | -0.0195 |
|---|
| 37468_at | JAK2 | Janus kinase 2 (a protein tyrosine kinase) | -0.0614 | 0.0193 |
|---|
| 32960_at | SMO | smoothened homolog (Drosophila) | 0.0612 | -0.0193 |
|---|
| 1745_at | RET | ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) | 0.0598 | -0.0188 |
|---|
| 36283_at | DDX6 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 | 0.0592 | -0.0187 |
|---|
| 735_s_at | AKAP13 | A kinase (PRKA) anchor protein 13 | -0.0587 | 0.0185 |
|---|
| 1623_s_at | FER | fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) | 0.058 | -0.0183 |
|---|
| 841_at | OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.0577 | -0.0182 |
|---|
| 1951_at | ANGPT2 | angiopoietin 2 | -0.0573 | 0.0181 |
|---|
| 1490_at | MYCL1 | v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) | 0.0572 | -0.018 |
|---|
| 37162_at | CCDC6 | coiled-coil domain containing 6 | -0.0562 | 0.0177 |
|---|
| 38545_at | INHBB | inhibin, beta B (activin AB beta polypeptide) | -0.0562 | 0.0177 |
|---|
| 961_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0562 | -0.0177 |
|---|
| 38509_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.056 | -0.0176 |
|---|
| 34324_at | CLN5 | ceroid-lipofuscinosis, neuronal 5 | 0.0559 | -0.0176 |
|---|
| 33043_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | 0.055 | -0.0173 |
|---|
| 2008_s_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.0549 | -0.0173 |
|---|
| 34740_at | FOXO3A | forkhead box O3A | -0.0548 | 0.0173 |
|---|
| 1333_f_at | BCR | breakpoint cluster region | -0.0544 | 0.0171 |
|---|
| 593_s_at | ROS1 | v-ros UR2 sarcoma virus oncogene homolog 1 (avian) | 0.0544 | -0.0171 |
|---|
| 1866_g_at | SKIL | SKI-like | 0.0543 | -0.0171 |
|---|
| 1203_at | INHBA | inhibin, beta A (activin A, activin AB alpha polypeptide) | -0.0541 | 0.017 |
|---|
| 1257_s_at | QSCN6 | quiescin Q6 | -0.0531 | 0.0167 |
|---|
| 34068_f_at | SSX1 | synovial sarcoma, X breakpoint 1 | -0.0528 | 0.0166 |
|---|
| 35044_i_at | BMP8B | bone morphogenetic protein 8b (osteogenic protein 2) | 0.0527 | -0.0166 |
|---|
| 940_g_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0524 | -0.0165 |
|---|
| 545_g_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.052 | -0.0164 |
|---|
| 31392_r_at | C1orf1 | chromosome 1 open reading frame 1 | -0.0518 | 0.0163 |
|---|
| 190_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.0514 | -0.0162 |
|---|
| 1728_at | BMI1 | B lymphoma Mo-MLV insertion region (mouse) | 0.0509 | -0.0161 |
|---|
| 36469_at | DTNA | dystrobrevin, alpha | 0.0507 | -0.016 |
|---|
| 40363_r_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.0494 | -0.0156 |
|---|
| 1601_s_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0493 | 0.0155 |
|---|
| 35133_at | FER | fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) | 0.0479 | -0.0151 |
|---|
| 35640_at | CBFA2T1 | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | -0.0478 | 0.0151 |
|---|
| 35147_at | MCF2L | MCF.2 cell line derived transforming sequence-like | 0.0475 | -0.015 |
|---|
| 1237_at | IER3 | immediate early response 3 | -0.0474 | 0.0149 |
|---|
| 31874_at | GAS2L1 | growth arrest-specific 2 like 1 | 0.0474 | -0.0149 |
|---|
| 1853_at | WNT1 | wingless-type MMTV integration site family, member 1 | -0.0474 | 0.0149 |
|---|
| 38377_at | MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | -0.0469 | 0.0148 |
|---|
| 34770_at | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.0467 | -0.0147 |
|---|
| 1743_s_at | SKIL | SKI-like | -0.0456 | 0.0144 |
|---|
| 1266_s_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.0452 | 0.0142 |
|---|
| 38627_at | HLF | hepatic leukemia factor | 0.0442 | -0.0139 |
|---|
| 1880_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.0433 | -0.0136 |
|---|
| 1837_at | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.0431 | -0.0136 |
|---|
| 40660_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.0404 | -0.0127 |
|---|
| 40977_f_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.0397 | 0.0125 |
|---|
| 1744_at | CCND1 | cyclin D1 (PRAD1 | 0.0396 | -0.0125 |
|---|
| 35563_at | MKL1 | megakaryoblastic leukemia (translocation) 1 | -0.0393 | 0.0124 |
|---|
| 38809_s_at | EXTL3 | exostoses (multiple)-like 3 | -0.0386 | 0.0122 |
|---|
| 1780_at | FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | -0.0385 | 0.0121 |
|---|
| 37829_at | GAS2 | growth arrest-specific 2 | -0.038 | 0.012 |
|---|
| 31604_at | GNAS | GNAS complex locus | 0.0379 | -0.0119 |
|---|
| 2026_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | -0.0375 | 0.0118 |
|---|
| 2060_at | BCL2 | B-cell CLL/lymphoma 2 | 0.0374 | -0.0118 |
|---|
| 37685_at | PICALM | phosphatidylinositol binding clathrin assembly protein | 0.0374 | -0.0118 |
|---|
| 160028_s_at | RET | ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) | -0.0369 | 0.0116 |
|---|
| 376_at | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.0367 | -0.0116 |
|---|
| 38289_r_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0363 | -0.0115 |
|---|
| 34664_at | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | 0.0357 | -0.0112 |
|---|
| 38491_at | ETV6 | ets variant gene 6 (TEL oncogene) | -0.0352 | 0.0111 |
|---|
| 41499_at | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.035 | -0.011 |
|---|
| 1891_at | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.0346 | -0.0109 |
|---|
| 1489_s_at | MYCL1 | v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) | 0.0339 | -0.0107 |
|---|
| 36471_f_at | DTNA | dystrobrevin, alpha | 0.0337 | -0.0106 |
|---|
| 34679_at | BCR | breakpoint cluster region | -0.0332 | 0.0105 |
|---|
| 36470_s_at | DTNA | dystrobrevin, alpha | 0.0328 | -0.0103 |
|---|
| 979_g_at | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | -0.0324 | 0.0102 |
|---|
| 39547_at | RANBP9 | RAN binding protein 9 | -0.0322 | 0.0101 |
|---|
| 1344_at | PAX3 | paired box gene 3 (Waardenburg syndrome 1) | 0.0315 | -0.0099 |
|---|
| 1539_at | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | -0.0315 | 0.0099 |
|---|
| 37810_at | HOXA9 | homeo box A9 | 0.0313 | -0.0099 |
|---|
| 535_s_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | -0.0312 | 0.0098 |
|---|
| 2020_at | CCND1 | cyclin D1 (PRAD1 | -0.0303 | 0.0096 |
|---|
| 36468_at | DTNA | dystrobrevin, alpha | 0.0301 | -0.0095 |
|---|
| 41562_at | BMI1 | B lymphoma Mo-MLV insertion region (mouse) | 0.0298 | -0.0094 |
|---|
| 41105_s_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.0296 | -0.0093 |
|---|
| 222_at | EXT1 | exostoses (multiple) 1 | 0.0295 | -0.0093 |
|---|
| 2078_s_at | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | -0.0294 | 0.0093 |
|---|
| 1865_at | SKIL | SKI-like | -0.029 | 0.0091 |
|---|
| 41854_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.0283 | 0.0089 |
|---|
| 1084_at | ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 0.0281 | -0.0089 |
|---|
| 638_at | HMGA2 | high mobility group AT-hook 2 | -0.0271 | 0.0085 |
|---|
| 38420_at | COL5A2 | collagen, type V, alpha 2 | 0.0265 | -0.0084 |
|---|
| 36409_f_at | SSX2 | synovial sarcoma, X breakpoint 2 | 0.0265 | -0.0083 |
|---|
| 1471_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0.0255 | -0.008 |
|---|
| 40044_at | ELL | elongation factor RNA polymerase II | -0.025 | 0.0079 |
|---|
| 38418_at | CCND1 | cyclin D1 (PRAD1 | 0.0244 | -0.0077 |
|---|
| 887_at | GDF1 | growth differentiation factor 1 | 0.0244 | -0.0077 |
|---|
| 1124_at | MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.024 | -0.0076 |
|---|
| 1339_s_at | BCR | breakpoint cluster region | -0.0232 | 0.0073 |
|---|
| 35673_at | ARHGEF5 | Rho guanine nucleotide exchange factor (GEF) 5 | 0.0231 | -0.0073 |
|---|
| 38900_at | PAX3 | paired box gene 3 (Waardenburg syndrome 1) | 0.0228 | -0.0072 |
|---|
| 41069_at | LECT1 | leukocyte cell derived chemotaxin 1 | 0.0225 | -0.0071 |
|---|
| 34416_at | CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | -0.022 | 0.0069 |
|---|
| 40624_at | OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.0213 | -0.0067 |
|---|
| 478_g_at | IRF5 | interferon regulatory factor 5 | -0.0212 | 0.0067 |
|---|
| 34379_at | ERAL1 | Era G-protein-like 1 (E. coli) | 0.0203 | -0.0064 |
|---|
| 32474_at | PAX7 | paired box gene 7 | 0.0202 | -0.0064 |
|---|
| 35158_at | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.0191 | -0.006 |
|---|
| 31872_at | SS18 | synovial sarcoma translocation, chromosome 18 | 0.0189 | -0.006 |
|---|
| 34069_s_at | SSX2 | synovial sarcoma, X breakpoint 2 | 0.0186 | -0.0059 |
|---|
| 1977_s_at | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.0185 | -0.0058 |
|---|
| 566_at | PML | promyelocytic leukemia | -0.0182 | 0.0057 |
|---|
| 1345_s_at | PAX3 | paired box gene 3 (Waardenburg syndrome 1) | -0.018 | 0.0057 |
|---|
| 35316_at | RRAGA | Ras-related GTP binding A | -0.0177 | 0.0056 |
|---|
| 36465_at | IRF5 | interferon regulatory factor 5 | -0.0175 | 0.0055 |
|---|
| 739_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | -0.0173 | 0.0055 |
|---|
| 1396_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0169 | 0.0053 |
|---|
| 36674_at | CCL4 | chemokine (C-C motif) ligand 4 | -0.016 | 0.005 |
|---|
| 1590_s_at | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | -0.0159 | 0.005 |
|---|
| 32963_s_at | RRAGD | Ras-related GTP binding D | -0.0151 | 0.0048 |
|---|
| 1881_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | -0.0144 | 0.0045 |
|---|
| 1236_s_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0144 | -0.0045 |
|---|
| 31399_at | BMP10 | bone morphogenetic protein 10 | -0.0132 | 0.0042 |
|---|
| 36466_at | DTNA | dystrobrevin, alpha | 0.0129 | -0.0041 |
|---|
| 1910_s_at | BCL2 | B-cell CLL/lymphoma 2 | 0.0127 | -0.004 |
|---|
| 978_at | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | 0.0127 | -0.004 |
|---|
| 377_g_at | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | -0.0125 | 0.0039 |
|---|
| 32164_at | EXT1 | exostoses (multiple) 1 | -0.012 | 0.0038 |
|---|
| 35701_at | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | -0.0116 | 0.0036 |
|---|
| 1888_s_at | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.0115 | -0.0036 |
|---|
| 37319_at | IGFBP3 | insulin-like growth factor binding protein 3 | 0.0115 | -0.0036 |
|---|
| 1806_at | MCF2 | MCF.2 cell line derived transforming sequence | -0.0111 | 0.0035 |
|---|
| 1882_g_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.0111 | -0.0035 |
|---|
| 31779_s_at | PRDM1 | PR domain containing 1, with ZNF domain | -0.0107 | 0.0034 |
|---|
| 1357_at | USP4 | ubiquitin specific protease 4 (proto-oncogene) | -0.0101 | 0.0032 |
|---|
| 773_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | -0.0095 | 0.003 |
|---|
| 1918_at | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.0095 | -0.003 |
|---|
| 36467_g_at | DTNA | dystrobrevin, alpha | 0.009 | -0.0028 |
|---|
| 32399_at | EVI1 | ecotropic viral integration site 1 | 0.0083 | -0.0026 |
|---|
| 35975_at | MLLT3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | -0.0075 | 0.0023 |
|---|
| 559_s_at | TLX1 | T-cell leukemia, homeobox 1 | 0.0063 | -0.002 |
|---|
| 1395_at | ARHC | ras homolog gene family, member C | -0.0052 | 0.0016 |
|---|
| 33773_at | MLLT10 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 | -0.0052 | 0.0016 |
|---|
| 32159_at | KRAS2 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | -0.0046 | 0.0015 |
|---|
| 39935_at | SKIL | SKI-like | -0.0045 | 0.0014 |
|---|
| 37310_at | PLAU | plasminogen activator, urokinase | -0.0044 | 0.0014 |
|---|
| 32754_at | TPM3 | tropomyosin 3 | 0.0038 | -0.0012 |
|---|
| 1807_g_at | MCF2 | MCF.2 cell line derived transforming sequence | 0.0037 | -0.0012 |
|---|
| 1614_s_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | 0.0034 | -0.0011 |
|---|
| 2005_s_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 0.0034 | -0.0011 |
|---|
| 36920_at | MTM1 | myotubular myopathy 1 | 0.0031 | -0.001 |
|---|
| 32359_at | WISP1 | WNT1 inducible signaling pathway protein 1 | -0.0022 | 7e-04 |
|---|
| 40662_g_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | -0.0022 | 7e-04 |
|---|
| 1678_g_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0017 | 5e-04 |
|---|
| 1586_at | IGFBP3 | insulin-like growth factor binding protein 3 | -0.0016 | 5e-04 |
|---|
| 2007_g_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | -0.0013 | 4e-04 |
|---|
| 37664_at | DRG2 | developmentally regulated GTP binding protein 2 | -4e-04 | 1e-04 |
|---|